Las últimas noticias médicas de HaemophiliaXpert Versión en línea Bienvenido, Leerá debajo las últimas publicaciones científicas de las principales revistas especializada en su área de competencia. Publicado el Viernes, 27 de marzo de 2026 Pain diagnostics in people with hemophilia – pain pressure thresholds and influence of age and joint status Journal of Thrombosis and Haemostasis 2026; 24(2): 470-82 Pain is a burden for people with hemophilia (PwH) and is often underdiagnosed. Therefore, it is crucial to develop accurate tools for pain assessment. Pain pressure thresholds (PPTs) are valuable in the... Versión HTML |  Versión PDF  |  Versión imprimible Missense and nonsense mutations and inhibitor development in patients with hemophilia A and B Journal of Thrombosis and Thrombolysis 2026; 59(1): 210-9 Hemophilia A and B are X-linked bleeding disorders caused by mutations in the F8 and F9 genes, leading to deficiencies in coagulation factors VIII (FVIII) and IX (FIX), respectively.... Versión HTML |  Versión PDF  |  Versión imprimible Analysis of Soluble and Humoral Immunological Parameters During Re-exposure with rFVIIIFc after History of Inhibitors. Hamostaseologie 2026 Feb Little is known on the mechanisms of tolerance to factor VIII (FVIII) in haemophilia A (HA) patients. To identify immunological markers in tolerance development, samples from two patients with HA treated... Leer más  |  Free Full-text Association of Patient-Reported Outcomes with Hemophilia A Inhibitor Status and Treatment Product Type. Journal of clinical medicine 2026 Feb; 15(4) We compared patient-reported outcomes (PROs) in persons with hemophilia A (PwHA) by inhibitor status and prescribed treatment products. Methods: Hematology Utilization Group VIII study enrolled PwHA aged... Leer más  |  Free Full-text Inicio  |  Noticias  |  Archivos Informar a un colega | Editar mi perfil | Darse de baja | Fuentes y criterios de la información Copyright 2026 © GNM Healthcare Group Companies USA, Inc.